Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 4.54
-14.3 %
$ 2.35 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-9.55 M
OPERATING CASH FLOW
-24.7 K
INVESTING CASH FLOW
7.52 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ENDRA Life Sciences Inc.
| Net Income | -10.1 M |
| Depreciation & Amortization | 275 K |
| Capital Expenditures | -33.9 K |
| Stock-Based Compensation | 996 K |
| Change in Working Capital | -923 K |
| Others | -76.2 K |
| Free Cash Flow | -9.58 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||
| Net Income | (10.1) | (13.2) | (11.2) | (11.7) | (13.3) | (9.8) | (5.4) | (2.8) | (2.3) | (2.2) |
| Depreciation & Amortization | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 68.3 K | 61.5 K | 64.9 K | 72.2 K | 37.2 K |
| Deferred Income Tax | 0 | 0 | 0 | (2.1) | 1.4 K | 0 | 0 | 0 | 25 K | 0 |
| Stock Based Compensation | 1.0 | 1.2 | 1.4 | 2.1 | 1.4 K | 1.37 K | 1 K | 0.2 | 0.3 | 0.3 |
| Other Operating Activities | 0.2 | 1.39 K | (0.3) | 2.3 | 4.0 | 2.4 | 1.7 | 0.9 | 0.7 | 0.6 |
| Change in Working Capital | (0.9) | (1.0) | (1.3) | (1.5) | 0.6 | (0.4) | 0.3 | 0.3 | 0.3 | (0.2) |
| Cash From Operations | (9.5) | (12.8) | (11.1) | (10.8) | (8.6) | (7.7) | (3.3) | (1.3) | (0.8) | (1.4) |
| INVESTING CASH FLOW | ||||||||||
| Capital Expenditures | 33.9 K | (0.2) | 45 K | 51.3 K | 43.6 K | 100 K | 7.86 K | 0 | (0.1) | (0.3) |
| Other Items | 9.16 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 24.7 K | (0.2) | 45 K | 51.3 K | 43.6 K | 100 K | 7.86 K | 0 | (0.1) | (0.3) |
| FINANCING CASH FLOW | ||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0.3 | 2.5 | 0.9 | 0.2 | 1.4 | 0 | 0 |
| Dividends Paid | 840 | 7.79 K | (0.1) | (0.4) | (4.2) | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.0 | 0 | 2.9 | 5.2 | 15.8 | 7.7 | 8.6 | 5 K | 0 | 0 |
| Cash From Financing Activities | 7.5 | 8.4 | 13.4 | 11.9 | 8.3 | 8.7 | 8.8 | 1.4 | 0.8 | 1.8 |
| CHANGE IN CASH | ||||||||||
| Net Change In Cash | (2.1) | (4.6) | 2.2 | 1.1 | (0.3) | 0.9 | 5.5 | 0.1 | (0.1) | 78.4 K |
| FREE CASH FLOW | ||||||||||
| Free Cash Flow | (9.6) | (13.0) | (11.2) | (10.8) | (8.6) | (7.8) | (3.3) | (1.3) | (1.0) | (1.7) |